Emily Feneberg

Advantages of routine next‐generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic

M. Turner, L. Ossher, K. Talbot, 2023, European journal of neurology.

Towards a TDP-43-Based Biomarker for ALS and FTLD

M. Turner, K. Talbot, E. Gray, 2018, Molecular Neurobiology.

Recent biomarker approaches in the diagnosis of frontotemporal lobar degeneration/Neurochemische Ansätze in der Diagnose der Frontotemporalen Lobärdegeneration

M. Neumann, P. Steinacker, M. Otto, 2012 .

Amyotrophic lateral sclerosis: the complex path to precision medicine

M. Turner, K. Talbot, Alexander G. Thompson, 2018, Journal of Neurology.

Parkinson’s disease therapy: what lies ahead?

P. Lingor, E. Feneberg, Nicolas U Schumacher, 2023, Journal of Neural Transmission.